Investigating the effect of senna on preparation for colonoscopy
- Conditions
- colonoscopy preparation.
- Registration Number
- IRCT20211101052935N1
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 362
People more than 18 year-old.
Giving a written consent.
Indications for colorectal cancer screening, include: average-risk screening, increased-risk screening (patients with one or more first degree relative[s] with colorectal cancer [CRC] or colorectal adenomas, hereditary CRC syndromes), positive fecal occult blood test, documented iron deficiency anemia in men or postmenopausal women.
Lower gastrointestinal symptoms such as unexplained chronic clinically significant diarrhea, or unexplained involuntary weight loss.
Abnormal abdominal imaging such as abnormalities detected on barium enema, abdominal computed tomography and etc.
Hypersensitivity to polyethylene glycol or senna
Taking laxatives within one week prior to colonoscopy
Previous colonic resection surgery
Known or suspected bowel obstruction
Prior history of colonoscopy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quality of colon preparation. Timepoint: During colonoscopy (within first 24 hours after use regimens). Method of measurement: Endoscopist report based on BBPS (Boston Bowel Preparation Scale).
- Secondary Outcome Measures
Name Time Method Adverse effects of preparation regimens. Timepoint: While taking the drug until colonoscopy. Method of measurement: patients report.